Study Casts Doubt on Effectiveness of TB Vaccine
Stanford MedicineThe tuberculosis vaccine known as BCG has been given to more people worldwide than any other vaccine, yet its effectiveness remains controversial. A new analysis by researchers at Stanford School of Medicine suggests that the bacterial strains used in current BCG vaccines have evolved in the laboratory and are now considerably weaker -- and less likely to provide protection from tuberculosis -- than the original vaccine developed about 75 years ago in France.